No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditions
|
- |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ labii (oris)
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of oral cavity
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of oral cavity
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 206 | 81 | 124 |
| Only index persons | 184 | 77 | 107 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 67.27 | 69.00 | 66.20 |
| Only index persons | 66.06 | 66.10 | 66.03 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 74 | 26 | 48 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 68.07 | 70.39 | 66.81 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 65
- Matched controls
- 649
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
150.0
27.1
27
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
48.7
15.4
18
5
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
+∞
15.2
14
*
130
Kela drug reimbursment
Malignant tumour
+∞
12.9
12
*
K13.29
ICD-10 Finland
Indefinite leukoplakia
+∞
12.9
12
*
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
27.2
11.3
15
7
D00.00
ICD-10 Finland
Cancer in situ on the lip red border
+∞
10.7
10
*
8070/2-C00.1
ICD-O-3
Squamous cell carcinoma in situ, NOS, of external lower lip
+∞
9.6
9
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
9.6
9
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.9
9.2
30
82
H02AB02
ATC
dexamethasone; systemic
58.1
8.9
10
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
24.0
8.8
12
6
K13.78
ICD-10 Finland
Other change in the oral mucosa
26.0
8.3
11
5
EP1AE
NOMESCO Finland
Neck ultrasound examination
15.9
8.3
13
10
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
+∞
7.4
7
*
A03FA01
ATC
metoclopramide; systemic, rectal
8.1
7.2
16
25
WX110
NOMESCO Finland
Local anesthesy
4.5
6.7
52
304
WX402
NOMESCO Finland
General anaesthesia
6.0
6.4
18
39
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
29.9
6.4
8
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
29.9
6.4
8
*
L57.0
ICD-10 Finland
Actinic keratosis
6.7
6.4
16
30
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
+∞
6.3
6
*
D00.05
ICD-10 Finland
In situ cancer of the pharyngeal part of the tongue
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
22
27
11.17
17.62
1.6
1.1
—
—
—
0
0
(4035726)
15
17
10.81
12.45
1.7
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
42
144
5.43
12.03
3.5
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
16
40
4.83
6.27
1.3
1.7
g/l
0.2
0.2
0.94
16
33
(3000991) Gas panel - Venous blood
16
42
4.58
5.90
10.7
6.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
43
223
3.22
5.72
5.3
3.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
33
151
3.14
5.37
3.9
2.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
29
136
2.86
4.37
3.1
2.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
35
182
2.75
4.33
3.1
2.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
30
147
2.75
4.13
3.1
2.4
e6/l
1.4
0.6
0.61
19
99
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
22
91
3.02
4.12
2.4
2.2
e6/l
0.3
1.1
1.88
13
51
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
10
24
4.66
4.03
11.8
5.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
21
86
3.01
3.99
2.5
2.5
e6/l
1.4
2.7
0.42
12
45
(3002582) Erythrocytes [#/volume] in Urine
31
159
2.63
3.86
3.4
2.6
e6/l
84.9
468.6
0.41
20
112
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
26
123
2.72
3.79
4.0
1.9
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
11
31
3.99
3.64
13.5
4.5
%
0.7
0.8
0.14
11
31
(3018095) Leukocytes [#/volume] in Urine
33
188
2.36
3.17
3.7
3.2
e6/l
75.9
53.9
0.16
21
124
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
35
3.52
3.07
1.8
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
42
272
2.26
2.93
9.8
5.2
mmol/l
1.2
1.2
0.95
37
233
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
14
54
2.96
2.90
2.4
1.6
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
10
31
3.57
2.89
14.7
4.5
%
0.9
1.6
—
10
31
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
14
55
2.91
2.81
2.0
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
6
8.82
2.79
1.4
2.3
%
9.5
14.2
—
5
6
(3000494) Fungus identified in Specimen by Culture
15
65
2.64
2.51
2.1
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
9
201
0.37
2.31
4.1
3.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
37
246
2.01
2.24
6.9
9.4
inr
1.6
1.3
—
8
67
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
17
83
2.36
2.23
2.8
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
20
3.75
2.11
1.4
2.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
29
183
1.96
1.98
5.2
5.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
13
59
2.46
1.98
1.5
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
11
4.79
1.97
6.0
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
21
119
2.07
1.92
1.3
1.7
nmol/l
1452.9
1216.3
0.41
14
89
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
35
2.78
1.87
2.1
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
12
4.38
1.85
1.8
2.7
%
50.6
64.4
—
5
12
(3052851) Hemolysis interference index of Serum or Plasma
6
19
3.34
1.70
1.5
3.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
40
292
1.80
1.68
3.3
2.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
25
159
1.86
1.63
10.0
3.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11
51
2.36
1.60
1.3
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
12
58
2.28
1.59
1.2
2.3
%
1.8
1.8
0.04
12
49
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
65
569
2.17
1.55
25.5
13.0
mg/l
40.1
23.1
1.95
55
453
(3024928) Oxygen saturation in Venous blood
5
15
3.49
1.55
1.8
3.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
9
39
2.48
1.49
9.7
3.9
mmol/l
24.0
24.5
—
9
39
(3012544) pH of Venous blood
12
62
2.12
1.37
2.5
4.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
21
133
1.81
1.37
1.6
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
10
48
2.25
1.35
1.4
1.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
8
34
2.51
1.34
2.0
2.7
%
0.6
0.6
—
8
34
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
35
2.44
1.31
2.0
2.6
%
1.7
1.4
—
8
35
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
33
243
1.65
1.25
1.9
2.0
pmol/l
98.1
94.9
0.14
14
119
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
30
217
1.64
1.21
2.0
2.3
nmol/l
82.5
76.0
0.48
25
185
(3021589) Normoblasts [#/volume] in Blood
32
237
1.62
1.17
7.5
8.6
e9/l
0.0
0.0
0.00
25
197
(3001604) Monocytes [#/volume] in Blood
36
276
1.59
1.13
6.0
5.1
e9/l
0.6
0.6
0.50
30
234
(40758558) Short blood count panel - Blood
19
125
1.70
1.08
7.7
5.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
36
279
1.57
1.07
6.0
5.1
e9/l
0.0
0.0
0.66
30
239
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
34
2.17
1.06
1.3
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
65
589
1.85
1.03
18.2
12.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
23
162
1.61
1.01
4.0
2.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
36
282
1.54
1.00
6.1
5.1
e9/l
1.6
1.8
1.59
31
245
(3037467) Urinalysis macro (dipstick) panel - Urine
44
363
1.52
0.95
4.5
4.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
29
2.16
0.91
1.2
1.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
65
594
1.77
0.91
29.8
15.6
umol/l
86.4
84.9
0.09
65
594
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
8
46
1.83
0.86
3.9
1.7
u/l
25.4
33.8
—
8
35
(3022145) Colonoscopy Study observation
8
48
1.75
0.82
1.3
1.3
—
—
—
0
0
(1002224) Polysomnography panel
0
25
0.00
0.80
0.0
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
10
157
0.58
0.80
2.8
2.0
umol/l
370.0
9891.9
—
10
136
(3009542) Hematocrit [Volume Fraction] of Blood
56
496
1.53
0.78
31.9
14.1
%
35.4
40.7
1.95
38
325
(3013650) Neutrophils [#/volume] in Blood by Automated count
37
304
1.43
0.76
12.2
6.2
e9/l
4.3
4.3
0.01
32
261
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
41
1.78
0.72
1.6
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
51
447
1.45
0.72
32.5
16.0
%
13.9
13.8
0.09
51
437
(3004588) Protein electrophoresis panel - Serum or Plasma
7
42
1.73
0.70
6.0
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
42
1.73
0.70
2.1
2.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
24
184
1.45
0.70
3.7
3.3
mg/l
44.6
421.1
0.57
18
120
(4010399)
7
43
1.69
0.69
1.6
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
49
1.71
0.65
1.4
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
7
111
0.59
0.64
5.1
4.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
10
148
0.63
0.63
3.2
3.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
16
212
0.69
0.60
3.1
3.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
24
189
1.40
0.60
3.5
3.0
mmol/l
5.1
7.6
5.00
19
150
(3013512) EKG study
14
188
0.69
0.56
4.8
4.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
9
62
1.51
0.56
2.2
2.1
—
—
—
0
0
(3044889) 12 lead EKG panel
45
396
1.35
0.55
4.1
3.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
47
418
1.34
0.53
3.6
3.5
pmol/l
15.0
15.0
0.05
42
375
(3042936) Bacteria identified in Isolate by Culture
12
87
1.45
0.45
4.0
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
31
1.66
0.44
1.2
2.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
59
549
1.37
0.44
7.2
6.6
mmol/mol
41.8
41.0
0.21
53
508
(3001019) Free T4 and TSH panel - Serum or Plasma
0
16
0.00
0.41
0.0
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
34
1.50
0.41
1.4
2.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
24
201
1.29
0.39
4.2
3.8
mg/mmol
7.7
11.4
0.36
16
124
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
72
1.45
0.39
6.2
8.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
16
127
1.33
0.37
2.3
3.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
56
522
1.30
0.37
25.1
12.0
ml/min/173m2
77.0
75.6
0.17
47
418
(3019225) pH of Specimen
7
52
1.38
0.32
12.0
3.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
53
1.35
0.32
2.4
3.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
52
548
0.83
0.24
4.5
4.2
mmol/l
1.6
1.3
0.87
45
494
(3000492) Spirometry study
5
39
1.30
0.23
1.2
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
5
40
1.27
0.23
1.8
3.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
54
563
0.85
0.19
4.8
4.7
mmol/l
1.5
1.4
0.31
46
512
(40768797) Stomach Pathology biopsy report
6
75
0.78
0.16
1.3
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
55
568
0.88
0.13
4.6
4.7
mmol/l
4.3
4.5
0.87
48
522
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
6
71
0.83
0.08
1.0
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
57
583
0.90
0.08
5.4
5.3
mmol/l
2.3
2.6
2.65
51
527
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
23
218
1.08
0.06
4.2
3.6
%
13.1
23.6
—
7
105
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
28
270
1.06
0.04
3.2
4.0
ng/l
28.0
54.7
1.28
19
211
(3015736) pH of Urine
20
204
0.97
0.00
2.9
3.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4027681)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
8
0.00
0.00
0.0
1.0
—
0.9
—
0
8
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
7
0.00
0.00
0.0
5.1
—
67.1
—
0
7
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4062490)
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.5
—
338.0
—
0
8
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.7
—
0
5
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
11.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
6.5
—
0
5
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
6
0.00
0.00
0.0
1.3
—
452.5
—
0
6
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
7
0.00
0.00
0.0
3.1
—
34.9
—
0
7
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
297.3
—
0
7
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
6
0.00
0.00
0.0
2.7
—
7.6
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint CD2_INSITU_ORALCAVITY_EXALLC and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have CD2_INSITU_ORALCAVITY_EXALLC.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: CD2_INSITU_ORALCAVITY_EXALLC – Carcinoma in situ of oral cavity
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data